Sarissa Capital Management as of June 30, 2026
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 24.1 | $43M | 1.9M | 22.71 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 21.7 | $39M | 9.2M | 4.21 | |
| Amarin Corp Sponsored Adr (AMRN) | 15.0 | $27M | 1.7M | 15.94 | |
| Neurocrine Biosciences (NBIX) | 11.0 | $20M | 117k | 168.53 | |
| Cytokinetics Com New (CYTK) | 10.9 | $20M | 229k | 85.19 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 10.4 | $19M | 167k | 110.94 | |
| Biohaven (BHVN) | 4.9 | $8.7M | 582k | 14.88 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $2.6M | 4.2k | 623.54 | |
| Vor Biopharma Com New (VOR) | 0.3 | $468k | 25k | 18.41 | |
| Biogen Idec (BIIB) | 0.1 | $205k | 950.00 | 216.06 |
